Bharat Parenterals Limited (BPLPHARMA.BO)
INR 1640.0
(0.33%)
INR 1640.0
(0.33%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 2.59 Billion | 2.17 Billion | 2.12 Billion | 2.04 Billion | 2.28 Billion | 2.19 Billion |
| Cost of Revenue | 1.6 Billion | 1.74 Billion | 1.68 Billion | 1.64 Billion | 1.8 Billion | 1.71 Billion |
| Gross Profit | 989.46 Million | 430.21 Million | 435.84 Million | 403.23 Million | 475.86 Million | 477.32 Million |
| Operating Expenses | 255.97 Million | 276.76 Million | 208.08 Million | 203.01 Million | 248.74 Million | 245.32 Million |
| Selling, General and Administrative Expenses | 245.37 Million | 266.09 Million | 193.44 Million | 184.85 Million | 225.77 Million | 221.94 Million |
| Research and Development Expenses | 10.6 Million | 10.49 Million | 14.18 Million | 17.1 Million | 21.62 Million | 22.72 Million |
| Other Expenses | - | -176 Thousand | -453 Thousand | -1.05 Million | -1.35 Million | -657 Thousand |
| Cost and Expenses | 1.86 Billion | 2.02 Billion | 1.89 Billion | 1.84 Billion | 2.05 Billion | 1.96 Billion |
| Operating Income | 733.49 Million | 153.44 Million | 227.76 Million | 200.22 Million | 227.11 Million | 232 Million |
| Interest Expense | 32.2 Million | 21.9 Million | 13.05 Million | 7.65 Million | 8.64 Million | 8.7 Million |
| Income Tax Expense | 82.07 Million | 78.32 Million | 70.64 Million | 68.08 Million | 86.52 Million | 133.45 Million |
| Earnings before Tax | 187.21 Million | 235.47 Million | 278.76 Million | 271.24 Million | 327.95 Million | 345.92 Million |
| Net Income | 145.17 Million | 164.4 Million | 210.52 Million | 203.89 Million | 241.43 Million | 212.47 Million |
| Earnings Per Share Basic | 24.94 | 28.47 | 36.67 | 35.59 | 42.14 | 37.08 |
| Earnings Per Share Diluted | 24.94 | 28.47 | 36.67 | 35.59 | 42.14 | 37.08 |
| Weighted Average Shares Outstanding | 5.82 Million | 5.77 Million | 5.74 Million | 5.72 Million | 5.72 Million | 5.72 Million |
| Weighted Average Shares Outstanding (Diluted) | 5.82 Million | 5.77 Million | 5.74 Million | 5.72 Million | 5.72 Million | 5.72 Million |
| Gross Margin | 0.38 | 0.20 | 0.21 | 0.20 | 0.21 | 0.22 |
| EBIT Margin | 0.10 | 0.10 | 0.14 | 0.13 | 0.13 | 0.13 |
| Profit Margin | 0.06 | 0.08 | 0.10 | 0.10 | 0.11 | 0.10 |
| EBITDA | 265.74 Million | 319.26 Million | 293.27 Million | 337.99 Million | 330.18 Million | 390.04 Million |
| Earnings Before Tax Margin | 0.28 | 0.07 | 0.11 | 0.10 | 0.10 | 0.11 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 716.3 Million | 925.1 Million | 2.57 Billion | 678.2 Million | 598.2 Million | 598 Million |
| Cost of Revenue | 613.3 Million | 545.7 Million | 2.06 Billion | 545.6 Million | 437.5 Million | 372.2 Million |
| Gross Profit | 103 Million | 379.4 Million | 506.64 Million | 132.6 Million | 160.7 Million | 225.8 Million |
| Operating Expenses | 269.8 Million | 99.2 Million | 350.59 Million | 161.4 Million | 112.7 Million | 174.1 Million |
| Selling, General and Administrative Expenses | 269.8 Million | 99.2 Million | - | 161.4 Million | 112.7 Million | 58.6 Million |
| Research and Development Expenses | - | - | - | 10.6 Million | - | - |
| Other Expenses | - | - | -11.03 Million | - | - | - |
| Cost and Expenses | 883.1 Million | 644.9 Million | 2.41 Billion | 707 Million | 550.2 Million | 546.3 Million |
| Operating Income | -166.8 Million | 280.2 Million | 156.05 Million | -28.8 Million | 48 Million | 25.6 Million |
| Interest Expense | 29.1 Million | 27.7 Million | 32.2 Million | 11.3 Million | 5.8 Million | - |
| Income Tax Expense | 21.4 Million | 40.76 Million | 82.07 Million | 12 Million | 18.2 Million | 21.1 Million |
| Earnings before Tax | -153.7 Million | -47.63 Million | 187.21 Million | -13.6 Million | 54.7 Million | 45.4 Million |
| Net Income | -75.1 Million | 12.8 Million | 145.17 Million | -3 Million | 37.8 Million | 35.2 Million |
| Earnings Per Share Basic | -11.51 | 2.20 | - | -0.52 | 6.55 | 6.07 |
| Earnings Per Share Diluted | -11.51 | 2.20 | - | -0.52 | 6.55 | 6.07 |
| Weighted Average Shares Outstanding | 6.52 Million | 5.81 Million | 5.82 Million | 5.81 Million | 5.77 Million | 5.79 Million |
| Weighted Average Shares Outstanding (Diluted) | 6.52 Million | 5.81 Million | 5.82 Million | 5.81 Million | 5.77 Million | 5.79 Million |
| Gross Margin | 0.14 | 0.41 | 0.20 | 0.20 | 0.27 | 0.38 |
| EBIT Margin | -0.05 | -0.02 | - | 0.01 | 0.11 | 0.07 |
| Profit Margin | -0.10 | 0.01 | 0.06 | -0.00 | 0.06 | 0.06 |
| EBITDA | -34.6 Million | -22.84 Million | - | 9.9 Million | 66.2 Million | 40.22 Million |
| Earnings Before Tax Margin | -0.23 | 0.30 | 0.06 | -0.04 | 0.08 | 0.04 |
3091
0LIU
002713
8967
002396
LRKKF